{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:55:59Z","timestamp":1780970159276,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.transci.2019.08.007","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T22:11:51Z","timestamp":1565302311000},"page":"572-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inherited disorders of the fibrinolytic pathway"],"prefix":"10.1016","volume":"58","author":[{"given":"Shilpa","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchitra S.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2019.08.007_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Cesarman-Maus","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.08.007_bib0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1538-7836.2008.03220.x","article-title":"New insights into the molecular mechanisms of the fibrinolytic system","volume":"7","author":"Rijken","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.2001.tb03511.x","article-title":"Elements of the fibrinolytic system","volume":"936","author":"Lijnen","year":"2001","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.transci.2019.08.007_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.transci.2019.08.007_bib0025","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1365-2516.2008.01766.x","article-title":"Alpha2-antiplasmin and its deficiency: fibrinolysis out of balance","volume":"14","author":"Carpenter","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.transci.2019.08.007_bib0030","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/858293","article-title":"Functional stability of plasminogen activator inhibitor-1","volume":"2014","author":"Yasar Yildiz","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/j.transci.2019.08.007_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.2012.09074.x","article-title":"PAI-1, progress in understanding the clinical problem and its aetiology","volume":"157","author":"Iwaki","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.08.007_bib0040","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1365-2516.2008.01834.x","article-title":"Plasminogen activator inhibitor type 1 deficiency","volume":"14","author":"Mehta","year":"2008","journal-title":"Haemophilia"},{"key":"10.1016\/j.transci.2019.08.007_bib0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0888-7543(92)90224-G","article-title":"Assignment of the human alpha 2-plasmin inhibitor gene (PLI) to chromosome 17, region pter-p12, by PCR analysis of somatic cell hybrids","volume":"13","author":"Welch","year":"1992","journal-title":"Genomics"},{"key":"10.1016\/j.transci.2019.08.007_bib0050","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1586\/ehm.11.5","article-title":"Quebec platelet disorder","volume":"4","author":"Hayward","year":"2011","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.transci.2019.08.007_bib0055","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1182\/blood-2009-07-233965","article-title":"Persons with Quebec platelet disorder have a tandem duplication of PLAU, the urokinase plasminogen activator gene","volume":"115","author":"Paterson","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.08.007_bib0060","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1182\/blood.V98.2.257","article-title":"Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator","volume":"98","author":"Kahr","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.08.007_bib0065","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1182\/blood-2008-08-175216","article-title":"Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes","volume":"113","author":"Diamandis","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.08.007_bib0070","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1160\/TH02-12-0323","article-title":"Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder","volume":"90","author":"Sheth","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0075","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1182\/blood.V87.12.4967.bloodjournal87124967","article-title":"An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defect","volume":"87","author":"Hayward","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.08.007_bib0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1182\/blood-2003-11-4077","article-title":"Bleeding risks associated with inheritance of the Quebec platelet disorder","volume":"104","author":"McKay","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.08.007_bib0085","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0031-1291382","article-title":"Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment","volume":"37","author":"Blavignac","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0090","doi-asserted-by":"crossref","DOI":"10.1111\/jth.14160","article-title":"Hemorrhagic disorders of fibrinolysis: a clinical review","author":"Saes","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0095","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s002470050513","article-title":"A case of intramedullary haematoma associated with congenital alpha2-plasmin inhibitor deficiency","volume":"28","author":"Devaussuzenet","year":"1998","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.transci.2019.08.007_bib0100","first-page":"321","article-title":"Intramedullary multiple hematomas in siblings with congenital alpha-2-plasmin inhibitor deficiency: orthopedic surgery with protection by tranexamic acid","volume":"21","author":"Takahashi","year":"1991","journal-title":"Haemostasis"},{"key":"10.1016\/j.transci.2019.08.007_bib0105","first-page":"328","article-title":"Alpha 2-antiplasmin deficiency. An overlooked cause of hemorrhage","volume":"15","author":"Griffin","year":"1993","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.transci.2019.08.007_bib0110","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0049-3848(85)90302-0","article-title":"Severe hemorrhagic tendency in heterozygous alpha 2-antiplasmin deficiency","volume":"40","author":"Kordich","year":"1985","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2019.08.007_bib0115","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/hae.12313","article-title":"The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: single-centre experience","volume":"20","author":"Heiman","year":"2014","journal-title":"Haemophilia"},{"key":"10.1016\/j.transci.2019.08.007_bib0120","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/107602960401000316","article-title":"Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report and literature review","volume":"10","author":"Repine","year":"2004","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0125","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.thromres.2011.10.008","article-title":"The first report of uncontrollable subchorionic and retroplacental haemorrhage inducing preterm labour in complete PAI-1 deficiency in a human","volume":"129","author":"Iwaki","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2019.08.007_bib0130","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/SMJ.0b013e3181faee7e","article-title":"Pregnancy complicated by plasminogen activator inhibitor type 1 deficiency","volume":"103","author":"Smith","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.transci.2019.08.007_bib0135","doi-asserted-by":"crossref","first-page":"12446","DOI":"10.1073\/pnas.92.26.12446","article-title":"Ovulation efficiency is reduced in mice that lack plasminogen activator gene function: functional redundancy among physiological plasminogen activators","volume":"92","author":"Leonardsson","year":"1995","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.transci.2019.08.007_bib0140","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/01.AOG.0000260873.94196.d6","article-title":"Fibrinolytic defects and recurrent miscarriage: a systematic review and meta-analysis","volume":"109","author":"Sotiriadis","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.transci.2019.08.007_bib0145","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2141.2001.02845.x","article-title":"Congenital alpha(2)-plasmin inhibitor deficiencies: a review","volume":"114","author":"Favier","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.transci.2019.08.007_bib0150","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1538-7836.2005.01709.x","article-title":"Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesis","volume":"4","author":"Agren","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0155","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1111\/j.1538-7836.2007.02585.x","article-title":"What is the clinical impact of low plasminogen activator inhibitor-1 (PAI-1) activity? A case report and study of the incidence of low PAI-1 antigen in a healthy population","volume":"5","author":"Santamaria","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/MBC.0b013e3282dded21","article-title":"Laboratory evidence of hyperfibrinolysis in association with low plasminogen activator inhibitor type 1 activity","volume":"18","author":"Agren","year":"2007","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.transci.2019.08.007_bib0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ajh.2830450104","article-title":"Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency","volume":"45","author":"Okajima","year":"1994","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2019.08.007_bib0170","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jpeds.2006.04.008","article-title":"Pediatric reference intervals for uncommon bleeding and thrombotic disorders","volume":"149","author":"Flanders","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.transci.2019.08.007_bib0175","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.12688","article-title":"Global assays of fibrinolysis","volume":"39","author":"Ilich","year":"2017","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.transci.2019.08.007_bib0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/MBC.0b013e328304e099","article-title":"Evaluation of urokinase plasminogen activator in urine from individuals with Quebec platelet disorder","volume":"19","author":"Diamandis","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.transci.2019.08.007_bib0185","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MBC.0b013e3282f41e3e","article-title":"Quebec platelet disorder: features, pathogenesis and treatment","volume":"19","author":"Diamandis","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.transci.2019.08.007_bib0190","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1538-7836.2006.01877.x","article-title":"Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis","volume":"4","author":"Diamandis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1538-7836.2005.01114.x","article-title":"Bleeding and thrombotic problems in a patient with alpha2 plasmin inhibitor deficiency","volume":"3","author":"Hayward","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2019.08.007_bib0200","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1378\/chest.97.6.1488","article-title":"Open-heart surgery in a patient with heterozygous alpha 2-antiplasmin deficiency. Perioperative strategies in the first reported case","volume":"97","author":"Shahian","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.transci.2019.08.007_bib0205","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0049-3848(80)90057-2","article-title":"Plasminogen activator response after DDAVP: a clinico-pharmacological study","volume":"20","author":"Mannucci","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.transci.2019.08.007_bib0210","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V97.6.1549","article-title":"Characterization of a novel autosomal dominant bleeding disorder in a large kindred from east Texas","volume":"97","author":"Kuang","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.08.007_bib0215","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1182\/blood-2014-08-592733","article-title":"A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function","volume":"125","author":"Cunha","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.transci.2019.08.007_bib0220","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1172\/JCI69091","article-title":"Coagulation factor V(A2440G) causes east Texas bleeding disorder via TFPIalpha","volume":"123","author":"Vincent","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2019.08.007_bib0225","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1073\/pnas.1310444110","article-title":"Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation","volume":"110","author":"Wood","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.transci.2019.08.007_bib0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11239-017-1488-y","article-title":"New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice","volume":"44","author":"Girolami","year":"2017","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.transci.2019.08.007_bib0235","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1172\/JCI71220","article-title":"Factor V, tissue factor pathway inhibitor, and east Texas bleeding disorder","volume":"123","author":"Broze","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.transci.2019.08.007_bib0240","doi-asserted-by":"crossref","first-page":"26950","DOI":"10.1016\/S0021-9258(19)74202-1","article-title":"Kinetics of factor Xa inhibition by tissue factor pathway inhibitor","volume":"268","author":"Huang","year":"1993","journal-title":"J Biol Chem"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219301521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050219301521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:50:34Z","timestamp":1761468634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050219301521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1473050219301521"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2019.08.007","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inherited disorders of the fibrinolytic pathway","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2019.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}